Key metrics and charts across all fundamental categories.
Stock price and market valuation
IRM trades at $130.59, a 51.8% increase year-over-year. Market capitalization stands at $38.77B, up 53.0% from the prior year. Track IRM price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$7.25B in TTM revenue grew 15.6% YoY, reaching $1.94B last quarter. TTM EBITDA of $2.36B on operating income of $395.23M shows growth is flowing through. Net income of $285.02M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
Price multiples and return ratios
At 136.0x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 5.4x and P/B of 0.0x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 20.4% is up 4.4% YoY — cost efficiency is improving. Net margin at 7.7%.
Free cash flow, earnings quality, and capital allocation
FCF of $-179.46M on $338.55M in operating cash flow. The FCF / Net Income ratio of -0.6x shows cash consumption — the business is not yet self-funding. Cash reserves of $250.71M provide financial flexibility. Share count is stable — no dilution or buyback activity.
